Dermatology Drug Industry Research Report 2024

Dermatology Drug Industry Research Report 2024


Summary

Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.

According to APO Research, The global Dermatology Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Dermatology Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Dermatology Drug include AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma and Valeant, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dermatology Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatology Drug.
The Dermatology Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatology Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
Dermatology Drug segment by Type

External Use
Oral
Injection
Dermatology Drug Segment by Application

Psoriasis
Skin Infections
Acne
Dermatitis
Others
Dermatology Drug Segment by Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dermatology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatology Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Dermatology Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Dermatology Drug by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 External Use
2.2.3 Oral
2.2.4 Injection
2.3 Dermatology Drug by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Psoriasis
2.3.3 Skin Infections
2.3.4 Acne
2.3.5 Dermatitis
2.3.6 Others
2.4 Assumptions and Limitations
3 Dermatology Drug Breakdown Data by Type
3.1 Global Dermatology Drug Historic Market Size by Type (2019-2024)
3.2 Global Dermatology Drug Forecasted Market Size by Type (2025-2030)
4 Dermatology Drug Breakdown Data by Application
4.1 Global Dermatology Drug Historic Market Size by Application (2019-2024)
4.2 Global Dermatology Drug Forecasted Market Size by Application (2019-2024)
5 Global Growth Trends
5.1 Global Dermatology Drug Market Perspective (2019-2030)
5.2 Global Dermatology Drug Growth Trends by Region
5.2.1 Global Dermatology Drug Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Dermatology Drug Historic Market Size by Region (2019-2024)
5.2.3 Dermatology Drug Forecasted Market Size by Region (2025-2030)
5.3 Dermatology Drug Market Dynamics
5.3.1 Dermatology Drug Industry Trends
5.3.2 Dermatology Drug Market Drivers
5.3.3 Dermatology Drug Market Challenges
5.3.4 Dermatology Drug Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Dermatology Drug Players by Revenue
6.1.1 Global Top Dermatology Drug Players by Revenue (2019-2024)
6.1.2 Global Dermatology Drug Revenue Market Share by Players (2019-2024)
6.2 Global Dermatology Drug Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Dermatology Drug Head office and Area Served
6.4 Global Dermatology Drug Players, Product Type & Application
6.5 Global Dermatology Drug Players, Date of Enter into This Industry
6.6 Global Dermatology Drug Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Dermatology Drug Market Size (2019-2030)
7.2 North America Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Dermatology Drug Market Size by Country (2019-2024)
7.4 North America Dermatology Drug Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Dermatology Drug Market Size (2019-2030)
8.2 Europe Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Dermatology Drug Market Size by Country (2019-2024)
8.4 Europe Dermatology Drug Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Dermatology Drug Market Size (2019-2030)
9.2 Asia-Pacific Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Dermatology Drug Market Size by Country (2019-2024)
9.4 Asia-Pacific Dermatology Drug Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 Latin America
10.1 Latin America Dermatology Drug Market Size (2019-2030)
10.2 Latin America Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Dermatology Drug Market Size by Country (2019-2024)
10.4 Latin America Dermatology Drug Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Dermatology Drug Market Size (2019-2030)
11.2 Middle East & Africa Dermatology Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Dermatology Drug Market Size by Country (2019-2024)
11.4 Middle East & Africa Dermatology Drug Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 Players Profiled
12.1 AbbVie
12.1.1 AbbVie Company Information
12.1.2 AbbVie Business Overview
12.1.3 AbbVie Revenue in Dermatology Drug Business (2019-2024)
12.1.4 AbbVie Dermatology Drug Product Portfolio
12.1.5 AbbVie Recent Developments
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Information
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Revenue in Dermatology Drug Business (2019-2024)
12.2.4 Johnson & Johnson Dermatology Drug Product Portfolio
12.2.5 Johnson & Johnson Recent Developments
12.3 Bayer
12.3.1 Bayer Company Information
12.3.2 Bayer Business Overview
12.3.3 Bayer Revenue in Dermatology Drug Business (2019-2024)
12.3.4 Bayer Dermatology Drug Product Portfolio
12.3.5 Bayer Recent Developments
12.4 Galderma
12.4.1 Galderma Company Information
12.4.2 Galderma Business Overview
12.4.3 Galderma Revenue in Dermatology Drug Business (2019-2024)
12.4.4 Galderma Dermatology Drug Product Portfolio
12.4.5 Galderma Recent Developments
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Information
12.5.2 Bristol-Myers Squibb Business Overview
12.5.3 Bristol-Myers Squibb Revenue in Dermatology Drug Business (2019-2024)
12.5.4 Bristol-Myers Squibb Dermatology Drug Product Portfolio
12.5.5 Bristol-Myers Squibb Recent Developments
12.6 Novartis
12.6.1 Novartis Company Information
12.6.2 Novartis Business Overview
12.6.3 Novartis Revenue in Dermatology Drug Business (2019-2024)
12.6.4 Novartis Dermatology Drug Product Portfolio
12.6.5 Novartis Recent Developments
12.7 Pfizer
12.7.1 Pfizer Company Information
12.7.2 Pfizer Business Overview
12.7.3 Pfizer Revenue in Dermatology Drug Business (2019-2024)
12.7.4 Pfizer Dermatology Drug Product Portfolio
12.7.5 Pfizer Recent Developments
12.8 Merz Pharma
12.8.1 Merz Pharma Company Information
12.8.2 Merz Pharma Business Overview
12.8.3 Merz Pharma Revenue in Dermatology Drug Business (2019-2024)
12.8.4 Merz Pharma Dermatology Drug Product Portfolio
12.8.5 Merz Pharma Recent Developments
12.9 Valeant
12.9.1 Valeant Company Information
12.9.2 Valeant Business Overview
12.9.3 Valeant Revenue in Dermatology Drug Business (2019-2024)
12.9.4 Valeant Dermatology Drug Product Portfolio
12.9.5 Valeant Recent Developments
12.10 LEO Pharma
12.10.1 LEO Pharma Company Information
12.10.2 LEO Pharma Business Overview
12.10.3 LEO Pharma Revenue in Dermatology Drug Business (2019-2024)
12.10.4 LEO Pharma Dermatology Drug Product Portfolio
12.10.5 LEO Pharma Recent Developments
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Company Information
12.11.2 GlaxoSmithKline Business Overview
12.11.3 GlaxoSmithKline Revenue in Dermatology Drug Business (2019-2024)
12.11.4 GlaxoSmithKline Dermatology Drug Product Portfolio
12.11.5 GlaxoSmithKline Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings